 |
|
Advances in the Treatment of Hypertension
Thomas G. Pickering, MD, DPhil
JAMA. 1999;281:114-116.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
The past year has seen a flurry of publications of large-scale clinical trials that may have major impact on the treatment of hypertensive patients. Most of these appeared after the November 1997 publication of the latest report of the Joint National Committee (JNC VI)1 and generally support its recommendations.
Nonpharmacological Treatment of Hypertension
The JNC VI paid much more attention than have previous JNC reports to nonpharmacological treatment of hypertension, particularly the Dietary Approaches to Stop Hypertension (DASH) diet.2 The traditional recommendations for controlling blood pressure by dietary means are to restrict salt and to lose weight. However, vegetarians generally have low blood pressure, and there is some evidence, albeit inconsistent, that dietary supplementation with potassium, calcium, and magnesium may also have beneficial effects on blood pressure. The DASH study showed that a combination diet rich in fruits and vegetables and in which saturated fat was replaced by low-fat . . . [Full Text of this Article]
Are Newer Antihypertensive Drugs Better Than  -Blockers and Diuretics?
Antihypertensive Drugs and Cancer
How Should Hypertension in the Elderly Be Treated?
How Should Hypertensive Patients With Type 2 Diabetes Be Treated?
How Low Should the Blood Pressure Be?
Author Affiliation: Hypertension Center, New York Presbyterian Hospital, New York, NY.
RELATED ARTICLE
January 13, 1999
JAMA. 1999;281(2):203-204.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Should {beta}-Blockers Be Used to Treat Hypertension in Elderly Patients?
Shaughnessy et al.
JAMA 1999;281:1988-1989.
FULL TEXT
|
